HOME >> BIOLOGY >> NEWS
Gene Therapy Enables Transplantation Without Immunosuppressive Drugs

Researchers at the University of Pennsylvania Medical Center, working in a rodent model, have succeeded in transplanting livers without the need for immunosuppressive drugs. In a scientific first, a gene therapy strategy was used to alter the donor liver prior to surgery so that the immune system of the recipient became permanently tolerant of the new organ. The new findings are reported in the February issue of Nature Medicine.

Although additional animal studies will be required before human clinical trials of the approach can be considered, the advantages of such a localized system for countering the immune-system rejection of newly engrafted organs are potentially significant. The powerful immunosuppressive drugs now required to allow a life-saving transplanted organ to survive in a recipient's body without rejection do their work only at a substantial cost to the overall well-being of the recipient.

"Currently, all immunosuppression is systemic and lifelong," says Kim M. Olthoff, MD, an assistant professor of surgery and lead author on the study. "So, to protect the new organ from rejection, long-term drugs that suppress the entire immune system must be given, making the person susceptible to infections, cancers, and a number of other complications, including nerve and kidney damage. In our study, a one-time gene therapy treatment of only the donor liver made the recipient's immune system tolerant of the new organ without the need for any further immunosuppression."

The technique developed by the Penn team makes use of an adenovirus -- a virus usually associated with the common cold -- that has been engineered to incorporate the gene that encodes for a protein called CTLA4Ig. The gene-bearing virus, referred to as a vector, is then introduced into an organ preservation solution used to maintain the liver after harvesting and prior to engraftment, resulting in uptake by the organ
'"/>

Contact: Franklin Hoke
hokef@mail.med.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
29-Jan-1998


Page: 1 2 3

Related biology news :

1. 1st International Conference on Cell Therapy for Cardiovascular Disease
2. National Cancer Gene Therapy Foundation gives $4.0 million in research grants
3. Braunschweig Prize 2003 for Molecular Cancer Therapy
4. Alliance for Cancer Gene Therapy announces $1.5 million in national grants to young investigators
5. New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy
6. Therapy hinders AIDS virus from evolving drug resistance, Hopkins researchers find
7. Invitation To Cover: American Society Of Gene Therapy Meeting
8. Gene Therapy For Pain
9. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy
10. Shock Therapy Exceeds Expectations In Cleaning Up Contaminated Soils
11. Penn Researchers Develop Gene Therapy Technique That Reverses Muscle Membrane Weakness In Muscular Dystrophy Variant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/3/2019)... ... October 01, 2019 , ... ... dispensing of chemicals, reagents, and medias and to be a more environmentally sustainable ... the culmination of years of experience and feedback from the original version we ...
(Date:9/30/2019)... N.C. (PRWEB) , ... September 30, 2019 , ... As ... and an accepted model for studying the development and diseases of the human heart, ... potential activities of the progeny heart muscle cells to be clearly and easily recorded. ...
(Date:9/25/2019)... NEW ORLEANS (PRWEB) , ... September 25, 2019 ... ... together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its inaugural ... the New Orleans BioInnovation Center in Louisiana. , Co-produced by Tulane University, ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... ... 2019 , ... As Keck Graduate Institute (KGI) students completing ... with a set of recommendations to enhance supply chain processes. Now the 2019 ... to a wider audience of industry leaders attending the 12th Annual Bio Supply ...
(Date:10/3/2019)... ... October 01, 2019 , ... Today ... itself, announced the midway point of its randomized research trial for individuals with ... to measure the efficacy of a non-invasive technology which compares tones delivered to ...
(Date:10/3/2019)... ... 2019 , ... Murrieta Genomics , the launch pad for genomic sequencing ... Silicon Valley at a special Life Science showcase event on October 10th, ... JJ Lake Business Center located at 340 E. Middlefield Road in Mountain View, California. ...
(Date:10/3/2019)... ... ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New England in ... discussed important design factors that currently limit the success of early stage stem cell ... trials, in his talk Dr. Sherley focused on the highly problematic practice ...
Breaking Biology Technology:
Cached News: